Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-04

Clinical Trial Update: A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia [Phase 2]

View source ↗

Summary

Results from a Phase 2 dose-finding trial of ETC-1002 (bempedoic acid) in adults with hypercholesterolemia have been posted, evaluating multiple doses to assess…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ETC-1002 (Bempedoic Acid) (bempedoic acid)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED | Results posted: 2024-03-04